Natalie Wildenradt | Investor Relations, Argot Partners |
Gerri Henwood | President and Chief Executive Officer |
Ryan Lake | Chief Financial Officer |
John Harlow | Executive Vice President, Commercial |
Michael Celano | Chief Operating Officer |
David Amsellem | Piper Jaffray |
Ken Trbovich | Janney Montgomery Scott LLC |
Scott Henry | ROTH Capital Partners |
Patrick Trucchio | Berenberg Capital Markets, LLC |
Jonathan Aschoff | National Securities Corporation |
Leland Gershell | Oppenheimer & Co. Inc. |
Good day, ladies and gentlemen, and welcome to the Recro Pharma First Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today's conference, Ms.